INTC

INTEL CORPeval run

10-K for period ending 2025-12-27gpt-6-luna@none · prompt v4$0.00093.5sfiling on sec.gov ↗

figures

field	value	statement row	printed	SEC
Total revenue	$52.9B	R1 Net revenue	52,853 millions	$52.9B ✓
Operating income	-$2.2B	R8 Operating income (loss)	(2,214) millions	-$2.2B ✓
Net income attributable to the company	-$267.0M	R15 Net income (loss) attributable to Intel	(267) millions	-$267.0M ✓
Diluted EPS	$-0.06	R17 Earnings (loss) per share attributable to Intel-diluted	(0.06)	$-0.06 ✓
Cash and cash equivalents	$14.3B	R3 Cash and cash equivalents	14,265 millions	$14.3B ✓
Total assets	$211.4B	R14 Total assets	211,429 millions	$211.4B ✓
Total liabilities	-	not printed on this statement	-	-
Total shareholders' equity attributable to the company	$114.3B	R31 Total Intel stockholders' equity	114,281 millions	$114.3B ✓
Net cash from operating activities	$9.7B	R22 Net cash provided by (used for) operating activities	9,697 millions	$9.7B ✓
Net cash from investing activities	-$14.8B	R31 Net cash provided by (used for) investing activities	(14,821) millions	-$14.8B ✓
Net cash from financing activities	$11.6B	R45 Net cash provided by (used for) financing activities	11,587 millions	$11.6B ✓

checks

assets = liabilities + equity · total assets equals total liabilities and equity
equity excludes minority interests · totalEquity excludes noncontrolling interests
net income is before preferred dividends · net income is not the after-preferred-dividends line
diluted EPS is for total net income · diluted EPS is for total net income
net income excludes minority interests · netIncome excludes noncontrolling interests
cash flows tie to the change in cash · operating + investing + financing (+ FX) equals the net change in cash

management's claims

No year-over-year claims about the headline figures were found in management's discussion.

trace

0locator (code)0.20s

{
  "tables": 287,
  "exhibits": [],
  "documents": 1
}

{
  "income": {
    "rows": 21,
    "scale": 1000000,
    "score": 49.75,
    "heading": "Consolidated Statements of Operations",
    "tableIndex": 128,
    "runnerUpScore": 30
  },
  "balance": {
    "rows": 35,
    "scale": 1000000,
    "score": 51.75,
    "heading": "Consolidated Balance Sheets",
    "tableIndex": 134,
    "runnerUpScore": 17.5
  },
  "cashflow": {
    "rows": 52,
    "scale": 1000000,
    "score": 55,
    "heading": "Consolidated Statements of Cash Flows",
    "tableIndex": 137,
    "runnerUpScore": 10
  }
}

1cash flow agent1.52s · 1818 tokens · $0.0002

{
  "rows": 52,
  "retryHint": null,
  "tableIndex": 137
}

{
  "figures": [
    {
      "note": "This is the operating activities section total, including changes in working capital.",
      "field": "operatingCashFlow",
      "scale": 1000000,
      "value": 9697000000,
      "printed": "9,697",
      "rowIndex": 22,
      "rowLabel": "Net cash provided by (used for) operating activities",
      "priorValue": 8288000000,
      "agentPrinted": "9,697",
      "failedChecks": [],
      "priorPrinted": "8,288",
      "groundingMismatch": false
    },
    {
      "note": "This is the investing activities section total.",
      "field": "investingCashFlow",
      "scale": 1000000,
      "value": -14821000000,
      "printed": "(14,821)",
      "rowIndex": 31,
      "rowLabel": "Net cash provided by (used for) investing activities",
      "priorValue": -18256000000,
      "agentPrinted": "(14,821)",
      "failedChecks": [],
      "priorPrinted": "(18,256)",
      "groundingMismatch": false
    },
    {
      "note": "This is the financing activities section total.",
      "field": "financingCashFlow",
      "scale": 1000000,
      "value": 11587000000,
      "printed": "11,587",
      "rowIndex": 45,
      "rowLabel": "Net cash provided by (used for) financing activities",
      "priorValue": 11138000000,
      "agentPrinted": "11,587",
      "failedChecks": [],
      "priorPrinted": "11,138",
      "groundingMismatch": false
    }
  ],
  "statement": "cashflow",
  "tableIndex": 137,
  "priorColumn": 1,
  "currentColumn": 0
}

2income statement agent1.73s · 1483 tokens · $0.0002

{
  "rows": 21,
  "retryHint": null,
  "tableIndex": 128
}

{
  "figures": [
    {
      "note": "Net revenue is the company-wide revenue total.",
      "field": "revenue",
      "scale": 1000000,
      "value": 52853000000,
      "printed": "52,853",
      "rowIndex": 1,
      "rowLabel": "Net revenue",
      "priorValue": 53101000000,
      "agentPrinted": "52,853",
      "failedChecks": [],
      "priorPrinted": "53,101",
      "groundingMismatch": false
    },
    {
      "note": "This is the statement’s operating income (loss) line.",
      "field": "operatingIncome",
      "scale": 1000000,
      "value": -2214000000,
      "printed": "(2,214)",
      "rowIndex": 8,
      "rowLabel": "Operating income (loss)",
      "priorValue": -11678000000,
      "agentPrinted": "(2,214)",
      "failedChecks": [],
      "priorPrinted": "(11,678)",
      "groundingMismatch": false
    },
    {
      "note": "This line reports net income attributable to Intel, excluding non-controlling interests.",
      "field": "netIncome",
      "scale": 1000000,
      "value": -267000000,
      "printed": "(267)",
      "rowIndex": 15,
      "rowLabel": "Net income (loss) attributable to Intel",
      "priorValue": -18756000000,
      "agentPrinted": "(267)",
      "failedChecks": [],
      "priorPrinted": "(18,756)",
      "groundingMismatch": false
    },
    {
      "note": "This is diluted earnings per share attributable to Intel.",
      "field": "epsDiluted",
      "scale": 1,
      "value": -0.06,
      "printed": "(0.06)",
      "rowIndex": 17,
      "rowLabel": "Earnings (loss) per share attributable to Intel-diluted",
      "priorValue": -4.38,
      "agentPrinted": "(0.06)",
      "failedChecks": [],
      "priorPrinted": "(4.38)",
      "groundingMismatch": false
    }
  ],
  "statement": "income",
  "tableIndex": 128,
  "priorColumn": 1,
  "currentColumn": 0
}

3balance sheet agent1.81s · 1367 tokens · $0.0002

{
  "rows": 35,
  "retryHint": null,
  "tableIndex": 134
}

{
  "figures": [
    {
      "note": "This is the balance sheet's cash and cash equivalents line.",
      "field": "cash",
      "scale": 1000000,
      "value": 14265000000,
      "printed": "14,265",
      "rowIndex": 3,
      "rowLabel": "Cash and cash equivalents",
      "priorValue": 8249000000,
      "agentPrinted": "14,265",
      "failedChecks": [],
      "priorPrinted": "8,249",
      "groundingMismatch": false
    },
    {
      "note": "This row prints total assets.",
      "field": "totalAssets",
      "scale": 1000000,
      "value": 211429000000,
      "printed": "211,429",
      "rowIndex": 14,
      "rowLabel": "Total assets",
      "priorValue": 196485000000,
      "agentPrinted": "211,429",
      "failedChecks": [],
      "priorPrinted": "196,485",
      "groundingMismatch": false
    },
    {
      "note": "The statement has no total liabilities line; total liabilities and equity is not a substitute.",
      "field": "totalLiabilities",
      "scale": 1000000,
      "value": null,
      "printed": null,
      "rowIndex": null,
      "rowLabel": null,
      "priorValue": null,
      "agentPrinted": null,
      "failedChecks": [],
      "priorPrinted": null,
      "groundingMismatch": false
    },
    {
      "note": "This is Intel stockholders' equity, excluding non-controlling interests.",
      "field": "totalEquity",
      "scale": 1000000,
      "value": 114281000000,
      "printed": "114,281",
      "rowIndex": 31,
      "rowLabel": "Total Intel stockholders' equity",
      "priorValue": 99270000000,
      "agentPrinted": "114,281",
      "failedChecks": [],
      "priorPrinted": "99,270",
      "groundingMismatch": false
    }
  ],
  "statement": "balance",
  "tableIndex": 134,
  "priorColumn": 1,
  "currentColumn": 0
}

4reconciler (code)0.00s

null

[
  {
    "name": "balance_identity",
    "detail": "total assets equals total liabilities and equity",
    "fields": [
      "totalAssets"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "totalEquity_attribution",
    "detail": "totalEquity excludes noncontrolling interests",
    "fields": [
      "totalEquity"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "netIncome_before_preferred",
    "detail": "net income is not the after-preferred-dividends line",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "epsDiluted_total",
    "detail": "diluted EPS is for total net income",
    "fields": [
      "epsDiluted"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "netIncome_attribution",
    "detail": "netIncome excludes noncontrolling interests",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "cash_flow_tie",
    "detail": "operating + investing + financing (+ FX) equals the net change in cash",
    "fields": [
      "operatingCashFlow",
      "investingCashFlow",
      "financingCashFlow"
    ],
    "passed": true,
    "skipped": false,
    "statement": "cashflow"
  }
]

5MD&A claims agent1.02s · 2338 tokens · $0.0002
```
null
```
```
[]
```

Income statement

table #128 · current period is figure column 1

0	Years Ended (In Millions, Except Per Share Amounts)	Dec 27, 2025	Dec 28, 2024	Dec 30, 2023
1	Net revenue← Total revenue	52,853	53,101	54,228
2	Cost of sales	34,478	35,756	32,517
3	Gross profit	18,375	17,345	21,711
4	Research and development	13,774	16,546	16,046
5	Marketing, general, and administrative	4,624	5,507	5,634
6	Restructuring and other charges	2,191	6,970	(62)
7	Operating expenses	20,589	29,023	21,618
8	Operating income (loss)← Operating income	(2,214)	(11,678)	93
9	Gains (losses) on equity investments, net	514	242	40
10	Interest and other, net	3,257	226	629
11	Income (loss) before taxes	1,557	(11,210)	762
12	Provision for (benefit from) taxes	1,531	8,023	(913)
13	Net income (loss)	26	(19,233)	1,675
14	Less: net income (loss) attributable to non-controlling interests	293	(477)	(14)
15	Net income (loss) attributable to Intel← Net income attributable to the company	(267)	(18,756)	1,689
16	Earnings (loss) per share attributable to Intel-basic	(0.06)	(4.38)	0.40
17	Earnings (loss) per share attributable to Intel-diluted← Diluted EPS	(0.06)	(4.38)	0.40
18	Weighted average shares of common stock outstanding:
19	Basic	4,530	4,280	4,190
20	Diluted	4,530	4,280	4,212

Balance sheet

table #134 · current period is figure column 1

0	(In Millions, Except Par Value)	Dec 27, 2025	Dec 28, 2024
1	Assets
2	Current assets:
3	Cash and cash equivalents← Cash and cash equivalents	14,265	8,249
4	Short-term investments	23,151	13,813
5	Accounts receivable, net	3,839	3,478
6	Inventories	11,618	12,198
7	Other current assets	10,815	9,586
8	Total current assets	63,688	47,324
9	Property, plant and equipment, net	105,414	107,919
10	Equity investments	8,512	5,383
11	Goodwill	23,912	24,693
12	Identified intangible assets, net	2,772	3,691
13	Other long-term assets	7,131	7,475
14	Total assets← Total assets	211,429	196,485
15	Liabilities and stockholders' equity
16	Current liabilities:
17	Accounts payable	9,882	12,556
18	Accrued compensation and benefits	3,990	3,343
19	Short-term debt	2,499	3,729
20	Income taxes payable	604	1,756
21	Other accrued liabilities	14,600	14,282
22	Total current liabilities	31,575	35,666
23	Debt	44,086	46,282
24	Other long-term liabilities	9,408	9,505
25	Commitments and Contingencies (Note 19)
26	Stockholders' equity:
27	Preferred stock, $0.001 par value, 50 shares authorized; none issued	-	-
28	Common stock, $0.001 par value, 10,000 shares authorized; 4,994 shares issued and outstanding (4,330 issued and outstanding in 2024) and capital in excess of par value	65,185	50,949
29	Accumulated other comprehensive income (loss)	113	(711)
30	Retained earnings	48,983	49,032
31	Total Intel stockholders' equity← Total shareholders' equity attributable to the company	114,281	99,270
32	Non-controlling interests	12,079	5,762
33	Total stockholders' equity	126,360	105,032
34	Total liabilities and stockholders' equity	211,429	196,485

Cash flow statement

table #137 · current period is figure column 1

0	Years Ended (In Millions)	Dec 27, 2025	Dec 28, 2024	Dec 30, 2023
1	Cash and cash equivalents, beginning of period	8,249	7,079	11,144
2	Cash flows provided by (used for) operating activities:
3	Net income (loss)	26	(19,233)	1,675
4	Adjustments to reconcile net income (loss) to net cash provided by operating activities:
5	Depreciation	10,757	9,951	7,847
6	Share-based compensation	2,434	3,410	3,229
7	Restructuring and other charges	476	3,491	(424)
8	Amortization of intangibles	949	1,428	1,755
9	(Gains) losses on equity investments, net	(514)	(246)	(42)
10	Mark-to-market (gains) losses on Escrowed Shares	1,796	-	-
11	(Gains) losses on divestitures	(5,323)	-	-
12	Deferred taxes	328	6,132	(2,033)
13	Impairments and net (gain) loss on retirement of property, plant and equipment	515	2,252	33
14	Changes in assets and liabilities:
15	Accounts receivable	(449)	(75)	731
16	Inventories	(138)	(1,105)	2,097
17	Accounts payable	297	634	(801)
18	Accrued compensation and benefits	788	(218)	(614)
19	Income taxes	(995)	(356)	(1,498)
20	Other assets and liabilities	(1,250)	2,223	(484)
21	Total adjustments	9,671	27,521	9,796
22	Net cash provided by (used for) operating activities← Net cash from operating activities	9,697	8,288	11,471
23	Cash flows provided by (used for) investing activities:
24	Additions to property, plant and equipment	(14,646)	(23,944)	(25,750)
25	Proceeds from capital-related government incentives	1,577	1,936	1,011
26	Purchases of short-term investments	(24,319)	(37,940)	(44,414)
27	Maturities and sales of short-term investments	15,387	41,463	44,077
28	Sales of equity investments	671	1,047	472
29	Proceeds from divestitures, net	6,157	-	-
30	Other investing	352	(818)	563
31	Net cash provided by (used for) investing activities← Net cash from investing activities	(14,821)	(18,256)	(24,041)
32	Cash flows provided by (used for) financing activities:
33	Issuance of commercial paper, net of issuance costs	3,493	7,349	-
34	Repayment of commercial paper	(3,493)	(7,349)	(3,944)
35	Partner contributions	5,108	12,714	1,511
36	Net proceeds from sales of subsidiary shares	921	-	2,959
37	Additions to property, plant and equipment	(3,026)	(1,178)	-
38	Issuance of long-term debt, net of issuance costs	-	2,975	11,391
39	Repayment of debt	(3,750)	(2,288)	(423)
40	Proceeds from sales of common stock through employee equity incentive plans	771	987	1,042
41	Net proceeds attributed to common stock and warrants issued, and Escrowed Shares	12,706	-	-
42	Restricted stock unit withholdings	(423)	(631)	(534)
43	Payment of dividends to stockholders	-	(1,599)	(3,088)
44	Other financing	(720)	158	(409)
45	Net cash provided by (used for) financing activities← Net cash from financing activities	11,587	11,138	8,505
46	Net increase (decrease) in cash and cash equivalents	6,463	1,170	(4,065)
47	Cash, cash equivalents, and restricted cash, end of period	14,712	8,249	7,079
48	Non-cash supplemental disclosures:
49	Acquisition of property, plant and equipment	4,952	8,125	4,804
50	Cash paid during the year for:
51	Interest, net of capitalized interest	1,106	987	613